Amicus Therapeutics Initiates Rolling Biologic License Application to the U.S. Food and Drug Administration for AT-GAA in Late-Onset Pompe Disease
On Track for Completing the BLA Submission in 1H2021 All PPQ Drug Substance and Drug Product Activities for Manufacturing Now...